{"id":355814,"date":"2025-08-29T02:52:52","date_gmt":"2025-08-29T02:52:52","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-harmony-biosciences-holdings\/"},"modified":"2025-08-29T02:52:52","modified_gmt":"2025-08-29T02:52:52","slug":"how-to-buy-harmony-biosciences-holdings","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/","title":{"rendered":"Harmony Biosciences Holdings, Inc. (HRMY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Harmony Biosciences Holdings, Inc. (HRMY) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334009,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-355814","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Harmony Biosciences Holdings, Inc. (HRMY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Harmony Biosciences Holdings, Inc. (HRMY) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Harmony Biosciences Holdings, Inc. (HRMY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Harmony Biosciences Holdings, Inc. (HRMY) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Harmony Biosciences Holdings, Inc. (HRMY) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizini, 2025 b\u00fcy\u00fcme kataliz\u00f6rlerini ve maksimum getiri i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma stratejisini \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Harmony Biosciences Holdings, Inc. (HRMY) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizini, 2025 b\u00fcy\u00fcme kataliz\u00f6rlerini ve maksimum getiri i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma stratejisini \u00f6\u011frenin."},"intro":"Uykululuk hastal\u0131\u011f\u0131 tedavisinde devrim yaratan ve tutarl\u0131 k\u00e2rlar sa\u011flayan bir \u015firketin bir par\u00e7as\u0131na sahip oldu\u011funuzu hayal edin. Harmony Biosciences (HRMY), ileri bilim ile g\u00fc\u00e7l\u00fc finansal performans\u0131 birle\u015ftiriyor\u2014b\u00fcy\u00fcyen sa\u011fl\u0131k sekt\u00f6r\u00fc i\u00e7inde b\u00fcy\u00fcme arayan yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel. Bu hissenin neden dikkatinizi hak etti\u011fini ve portf\u00f6y\u00fcn\u00fcze nas\u0131l ekleyebilece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Uykululuk hastal\u0131\u011f\u0131 tedavisinde devrim yaratan ve tutarl\u0131 k\u00e2rlar sa\u011flayan bir \u015firketin bir par\u00e7as\u0131na sahip oldu\u011funuzu hayal edin. Harmony Biosciences (HRMY), ileri bilim ile g\u00fc\u00e7l\u00fc finansal performans\u0131 birle\u015ftiriyor\u2014b\u00fcy\u00fcyen sa\u011fl\u0131k sekt\u00f6r\u00fc i\u00e7inde b\u00fcy\u00fcme arayan yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel. Bu hissenin neden dikkatinizi hak etti\u011fini ve portf\u00f6y\u00fcn\u00fcze nas\u0131l ekleyebilece\u011finizi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 HRMY Hisse Analizi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2> <p>29 A\u011fustos 2025 itibar\u0131yla Harmony Biosciences Holdings (HRMY), NASDAQ'ta <strong>37,52 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. \u015eirket, biyoteknoloji sekt\u00f6r\u00fcndeki dalgalanmalara ra\u011fmen etkileyici bir istikrar g\u00f6sterdi; haftal\u0131k volatilite sadece <strong>%4,2<\/strong> iken, ila\u00e7 sekt\u00f6r\u00fc ortalamas\u0131 %10,2'dir (<a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-hrmy\/harmony-biosciences-holdings\">Simply Wall St<\/a>).<\/p> <p><strong>Takviminize not edin: 4 Kas\u0131m 2025<\/strong>, HRMY yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in son derece kritik bir tarih. \u015eirketin 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 g\u00fcn\u2014tarihsel olarak bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden olur.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 HRMY Hisselerini Nas\u0131l Etkiler?<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Fiyat Etkisi<\/th><th>S\u00fcre<\/th><\/tr> <\/thead> <tbody> <tr><td>5 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>Kar\u0131\u015f\u0131k tepki<\/td><td>Devam ediyor<\/td><\/tr> <tr><td>6 May 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>%7,3 art\u0131\u015f<\/td><td>1 hafta<\/td><\/tr> <tr><td>25 \u015eub 2025<\/td><td>2024 4. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>%5,1 art\u0131\u015f<\/td><td>3 g\u00fcn<\/td><\/tr> <tr><td>5 Kas 2024<\/td><td>\u00d6nceki 3. \u00c7eyrek<\/td><td>%4,8 art\u0131\u015f<\/td><td>2 hafta<\/td><\/tr> <\/tbody> <\/table> <p>Model, <strong>pozitif kazan\u00e7 s\u00fcrprizlerinin genellikle a\u00e7\u0131klamadan sonraki g\u00fcnlerde %5-7 aras\u0131 kazan\u00e7 sa\u011flad\u0131\u011f\u0131n\u0131<\/strong> g\u00f6steriyor. En son 2. \u00e7eyrek raporu gelir art\u0131\u015f\u0131 ile kar\u0131\u015f\u0131k sinyaller verdi ancak EPS beklentisi kar\u015f\u0131lanmad\u0131; bu nedenle Kas\u0131m raporu b\u00fcy\u00fcme yolunu do\u011frulamak i\u00e7in \u00f6zellikle \u00f6nemli.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: \u0130stikrarl\u0131 T\u0131rman\u0131\u015f ve H\u0131zlanma<\/h2> <p>HRMY hisseleri son alt\u0131 ayda <strong>etkileyici getiriler<\/strong> sa\u011flad\u0131:<\/p> <p><strong>Ocak 2025<\/strong>: 34,20 $ - Tatil sonras\u0131 konsolidasyon<br\/> <strong>Mart 2025<\/strong>: 36,80 $ - 1. \u00e7eyrek kazan\u00e7 beklentisi art\u0131\u015f\u0131<br\/> <strong>May\u0131s 2025<\/strong>: 38,50 $ - G\u00fc\u00e7l\u00fc 1. \u00e7eyrek sonu\u00e7lar\u0131 (%20 Y\u0131ll\u0131k gelir art\u0131\u015f\u0131)<br\/> <strong>Temmuz 2025<\/strong>: 39,20 $ - Yaz rallisi, pipeline haberleriyle<br\/> <strong>A\u011fustos 2025<\/strong>: 37,52 $ - K\u00fc\u00e7\u00fck geri \u00e7ekilme sonras\u0131 mevcut seviye<\/p> <p>Hisse bu d\u00f6nemde yakla\u015f\u0131k <strong>%9,7<\/strong> de\u011fer kazand\u0131 ve %12,6 d\u00fc\u015fen genel ila\u00e7 sekt\u00f6r\u00fcn\u00fc \u00f6nemli \u00f6l\u00e7\u00fcde geride b\u0131rakt\u0131 (<a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-hrmy\/harmony-biosciences-holdings\">Sekt\u00f6r Performans Verisi<\/a>). Bu \u00fcst\u00fcn performans, WAKIX'in ticari ba\u015far\u0131s\u0131 ve \u015firketin nadir n\u00f6rolojik hastal\u0131klardaki benzersiz konumundan kaynaklan\u0131yor.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 42-48 $ (mevcut seviyelerden %20-30 y\u00fckseli\u015f)<\/li> <li><strong>2026 Hedefi<\/strong>: 55-65 $ (WAKIX pazar geni\u015flemesi + pipeline kataliz\u00f6rleri)<\/li> <li><strong>2028 Projeksiyonu<\/strong>: 75-90 $ (\u00c7oklu \u00fcr\u00fcn lansmanlar\u0131 + uluslararas\u0131 b\u00fcy\u00fcme)<\/li> <li><strong>2030 Vizyonu<\/strong>: 100+ $ (Nadir n\u00f6roloji pazar liderli\u011fi + sat\u0131n almalar)<\/li> <\/ul> <p><strong>15 analist<\/strong> aras\u0131nda genel g\u00f6r\u00fc\u015f olduk\u00e7a olumlu; ortalama fiyat hedefi <strong>50,69 $<\/strong> olup bu %35 y\u00fckseli\u015f potansiyeline i\u015faret ediyor (<a href=\"https:\/\/public.com\/stocks\/hrmy\/forecast-price-target\">Analist Konsens\u00fcs\u00fc<\/a>). Tavsiye da\u011f\u0131l\u0131m\u0131 %53 G\u00fc\u00e7l\u00fc Al ve %33 Al \u015feklindedir.<\/p> <p><strong>Sonu\u00e7: UZUN VADEL\u0130 YATIRIMCILAR \u0130\u00c7\u0130N G\u00dc\u00c7L\u00dc AL<\/strong>. Mevcut k\u00e2rl\u0131l\u0131k, b\u00fcy\u00fcme e\u011filimi ve pipeline potansiyelinin birle\u015fimi HRMY'yi son derece cazip k\u0131l\u0131yor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Tek \u00fcr\u00fcn ba\u011f\u0131ml\u0131l\u0131\u011f\u0131<\/strong>: WAKIX, 2030'a kadar gelirlerin \u00e7o\u011funu olu\u015fturuyor<\/li> <li><strong>Patent s\u00fcresi dolmas\u0131<\/strong>: Ocak 2030 sonras\u0131 jenerik rekabet m\u00fcmk\u00fcn<\/li> <li><strong>Reg\u00fclasyon zorluklar\u0131<\/strong>: De\u011fi\u015fen sa\u011fl\u0131k politikalar\u0131 fiyatlamay\u0131 etkileyebilir<\/li> <li><strong>Pipeline uygulamas\u0131<\/strong>: Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131 yat\u0131r\u0131mc\u0131 g\u00fcvenini sarsabilir<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>WAKIX hakimiyeti<\/strong>: 2025 2. \u00e7eyrekte %16 Y\u0131ll\u0131k b\u00fcy\u00fcme, 400 yeni hasta<\/li> <li><strong>Pipeline \u00e7e\u015fitlendirmesi<\/strong>: 13 programda 8 varl\u0131k geli\u015ftirme a\u015famas\u0131nda<\/li> <li><strong>Mali g\u00fc\u00e7<\/strong>: 610 milyon $ nakit rezerv + d\u00f6rt y\u0131l k\u00e2rl\u0131l\u0131k<\/li> <li><strong>Pazar geni\u015flemesi<\/strong>: Y\u0131ll\u0131k 3 milyar $+ gelir potansiyeli hedefleniyor<\/li> <li><strong>Son ortakl\u0131k<\/strong>: N\u00f6rolojik tedaviler i\u00e7in Circ Biosciences ile i\u015f birli\u011fi<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-5'ini temsil eden pozisyonla ba\u015flay\u0131n<\/li> <li><strong>Ortalama maliyetle al\u0131m<\/strong>: Kazan\u00e7 tarihleri civar\u0131nda kademeli al\u0131m yap\u0131n<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Daha iyi giri\u015f i\u00e7in 36 $ alt\u0131 d\u00fc\u015f\u00fc\u015fleri takip edin<\/li> <li><strong>Uzun vadeye odaklan\u0131n<\/strong>: Bu, g\u00fcn de\u011fil y\u0131llarla \u00f6l\u00e7\u00fclen bir b\u00fcy\u00fcme hikayesi<\/li> <\/ol> <p>Espiri: \"HRMY ticareti, uykululu\u011fu tedavi etmek gibidir\u2014uyanma \u00e7a\u011fr\u0131s\u0131 i\u00e7in sabra ihtiyac\u0131n\u0131z var. Acele etmek f\u0131rsatlar\u0131 ka\u00e7\u0131r\u0131r!\"<\/p> <h2>\u2705 Harmony Biosciences Holdings, Inc. (HRMY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ticaret platformu se\u00e7in<\/td><td>NASDAQ eri\u015fimi ve d\u00fc\u015f\u00fck komisyon \u00fccretleri sa\u011flay\u0131n<\/td><\/tr> <tr><td>2<\/td><td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Risk alabilece\u011finiz y\u00f6netilebilir bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"HRMY\" aramas\u0131 yap\u0131n<\/td><td>Do\u011fru g\u00fcvenlik i\u00e7in tam sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>\u0130\u015flem \u00f6ncesi emir detaylar\u0131n\u0131 \u00e7ift kontrol edin<\/td><\/tr> <tr><td>6<\/td><td>Pozisyonu izleyin<\/td><td>Kazan\u00e7 ve haber olaylar\u0131 i\u00e7in uyar\u0131lar kurun<\/td><\/tr> <tr><td>7<\/td><td>Yeniden yat\u0131r\u0131m d\u00fc\u015f\u00fcn\u00fcn<\/td><td>Zay\u0131fl\u0131kta pozisyona ekleme planlay\u0131n<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden \u00dcst\u00fcn?<\/h2> <p>Pocket Option, HRMY gibi hisselerle yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in ola\u011fan\u00fcst\u00fc avantajlar sunar:<\/p> <p><strong>Sadece 5 $ minimum depozito<\/strong>, ger\u00e7ek piyasa ko\u015fullar\u0131na eri\u015firken stratejileri d\u00fc\u015f\u00fck riskle test etmenizi sa\u011flar. Platformun <strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong> sayesinde tek bir kimlik belgesi y\u00fckleyip hemen i\u015flem yapmaya ba\u015flayabilirsiniz\u2014kazan\u00e7 a\u00e7\u0131klamalar\u0131 \u00e7evresinde f\u0131rsatlar\u0131 yakalamak i\u00e7in ideal.<\/p> <p><strong>100'den fazla para \u00e7ekme y\u00f6ntemi<\/strong> (kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil) ile yat\u0131r\u0131m getirilerinizi y\u00f6netmede esneklik sa\u011flars\u0131n\u0131z. D\u00fc\u015f\u00fck giri\u015f engelleri ve g\u00fc\u00e7l\u00fc ticaret ara\u00e7lar\u0131n\u0131n birle\u015fimi, Pocket Option'u HRMY pozisyonunuzu ad\u0131m ad\u0131m olu\u015fturmak i\u00e7in ideal k\u0131lar.<\/p> <h2>\ud83c\udf0d 2025'te Harmony Biosciences: N\u00f6rolojinin Y\u00fckselen Y\u0131ld\u0131z\u0131<\/h2> <p>Harmony Biosciences, tek \u00fcr\u00fcnl\u00fc bir \u015firketten <strong>\"yenilik\u00e7i, kataliz\u00f6r zengini, kendi kendini finanse eden bir biyoteknoloji \u015firketi\"<\/strong> haline geldi ve y\u0131ll\u0131k 3 milyar $ \u00fczeri gelir potansiyeli hedefliyor (<a href=\"https:\/\/www.prnewswire.com\/news-releases\/harmony-biosciences-highlights-new-data-robust-late-stage-pipeline-with-near-term-value-creation-opportunities-and-its-bold-new-vision-at-investor-day-302263357.html\">\u015eirket Vizyonu<\/a>). Uykululuk hastal\u0131\u011f\u0131 i\u00e7in amiral gemisi WAKIX tedavisinin \u00f6tesinde, \u015firket art\u0131k 13 geli\u015ftirme program\u0131nda 8 varl\u0131\u011fa sahip.<\/p> <p>\u015eirketin finansal g\u00f6stergeleri biyoteknoloji sekt\u00f6r\u00fc i\u00e7in ola\u011fan\u00fcst\u00fcd\u00fcr: <strong>%78,34 br\u00fct marj<\/strong> ve <strong>%23,42 net k\u00e2r marj\u0131<\/strong> hem bilimsel yenilik hem de ticari m\u00fckemmeliyet g\u00f6steriyor (<a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-hrmy\/harmony-biosciences-holdings\">Finansal Analiz<\/a>). 610 milyon $ nakit rezerv ve s\u00fcrekli k\u00e2rl\u0131l\u0131kla Harmony, \u00e7o\u011fu \u015firketin ba\u015far\u0131ya ula\u015fmadan y\u0131llarca nakit yakt\u0131\u011f\u0131 bir sekt\u00f6rde \u00f6ne \u00e7\u0131k\u0131yor.<\/p> <p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025'te Harmony, SLEEP konferans\u0131nda BP1.15205 i\u00e7in \u00e7\u0131\u011f\u0131r a\u00e7an preklinik veriler sundu; bu deneysel bile\u015fik, uykululuk hastal\u0131\u011f\u0131 i\u00e7in s\u0131n\u0131f\u0131n\u0131n en iyisi tedavi olabilir\u2014uyku bozukluklar\u0131 tedavisinde bir kez daha devrim yaratma potansiyeline sahip!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 HRMY Hisse Analizi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2>\n<p>29 A\u011fustos 2025 itibar\u0131yla Harmony Biosciences Holdings (HRMY), NASDAQ&#8217;ta <strong>37,52 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. \u015eirket, biyoteknoloji sekt\u00f6r\u00fcndeki dalgalanmalara ra\u011fmen etkileyici bir istikrar g\u00f6sterdi; haftal\u0131k volatilite sadece <strong>%4,2<\/strong> iken, ila\u00e7 sekt\u00f6r\u00fc ortalamas\u0131 %10,2&#8217;dir (<a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-hrmy\/harmony-biosciences-holdings\">Simply Wall St<\/a>).<\/p>\n<p><strong>Takviminize not edin: 4 Kas\u0131m 2025<\/strong>, HRMY yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in son derece kritik bir tarih. \u015eirketin 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 g\u00fcn\u2014tarihsel olarak bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketlerine neden olur.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 HRMY Hisselerini Nas\u0131l Etkiler?<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Fiyat Etkisi<\/th>\n<th>S\u00fcre<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>5 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>Kar\u0131\u015f\u0131k tepki<\/td>\n<td>Devam ediyor<\/td>\n<\/tr>\n<tr>\n<td>6 May 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>%7,3 art\u0131\u015f<\/td>\n<td>1 hafta<\/td>\n<\/tr>\n<tr>\n<td>25 \u015eub 2025<\/td>\n<td>2024 4. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>%5,1 art\u0131\u015f<\/td>\n<td>3 g\u00fcn<\/td>\n<\/tr>\n<tr>\n<td>5 Kas 2024<\/td>\n<td>\u00d6nceki 3. \u00c7eyrek<\/td>\n<td>%4,8 art\u0131\u015f<\/td>\n<td>2 hafta<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Model, <strong>pozitif kazan\u00e7 s\u00fcrprizlerinin genellikle a\u00e7\u0131klamadan sonraki g\u00fcnlerde %5-7 aras\u0131 kazan\u00e7 sa\u011flad\u0131\u011f\u0131n\u0131<\/strong> g\u00f6steriyor. En son 2. \u00e7eyrek raporu gelir art\u0131\u015f\u0131 ile kar\u0131\u015f\u0131k sinyaller verdi ancak EPS beklentisi kar\u015f\u0131lanmad\u0131; bu nedenle Kas\u0131m raporu b\u00fcy\u00fcme yolunu do\u011frulamak i\u00e7in \u00f6zellikle \u00f6nemli.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: \u0130stikrarl\u0131 T\u0131rman\u0131\u015f ve H\u0131zlanma<\/h2>\n<p>HRMY hisseleri son alt\u0131 ayda <strong>etkileyici getiriler<\/strong> sa\u011flad\u0131:<\/p>\n<p><strong>Ocak 2025<\/strong>: 34,20 $ &#8211; Tatil sonras\u0131 konsolidasyon<br \/> <strong>Mart 2025<\/strong>: 36,80 $ &#8211; 1. \u00e7eyrek kazan\u00e7 beklentisi art\u0131\u015f\u0131<br \/> <strong>May\u0131s 2025<\/strong>: 38,50 $ &#8211; G\u00fc\u00e7l\u00fc 1. \u00e7eyrek sonu\u00e7lar\u0131 (%20 Y\u0131ll\u0131k gelir art\u0131\u015f\u0131)<br \/> <strong>Temmuz 2025<\/strong>: 39,20 $ &#8211; Yaz rallisi, pipeline haberleriyle<br \/> <strong>A\u011fustos 2025<\/strong>: 37,52 $ &#8211; K\u00fc\u00e7\u00fck geri \u00e7ekilme sonras\u0131 mevcut seviye<\/p>\n<p>Hisse bu d\u00f6nemde yakla\u015f\u0131k <strong>%9,7<\/strong> de\u011fer kazand\u0131 ve %12,6 d\u00fc\u015fen genel ila\u00e7 sekt\u00f6r\u00fcn\u00fc \u00f6nemli \u00f6l\u00e7\u00fcde geride b\u0131rakt\u0131 (<a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-hrmy\/harmony-biosciences-holdings\">Sekt\u00f6r Performans Verisi<\/a>). Bu \u00fcst\u00fcn performans, WAKIX&#8217;in ticari ba\u015far\u0131s\u0131 ve \u015firketin nadir n\u00f6rolojik hastal\u0131klardaki benzersiz konumundan kaynaklan\u0131yor.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 42-48 $ (mevcut seviyelerden %20-30 y\u00fckseli\u015f)<\/li>\n<li><strong>2026 Hedefi<\/strong>: 55-65 $ (WAKIX pazar geni\u015flemesi + pipeline kataliz\u00f6rleri)<\/li>\n<li><strong>2028 Projeksiyonu<\/strong>: 75-90 $ (\u00c7oklu \u00fcr\u00fcn lansmanlar\u0131 + uluslararas\u0131 b\u00fcy\u00fcme)<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 100+ $ (Nadir n\u00f6roloji pazar liderli\u011fi + sat\u0131n almalar)<\/li>\n<\/ul>\n<p><strong>15 analist<\/strong> aras\u0131nda genel g\u00f6r\u00fc\u015f olduk\u00e7a olumlu; ortalama fiyat hedefi <strong>50,69 $<\/strong> olup bu %35 y\u00fckseli\u015f potansiyeline i\u015faret ediyor (<a href=\"https:\/\/public.com\/stocks\/hrmy\/forecast-price-target\">Analist Konsens\u00fcs\u00fc<\/a>). Tavsiye da\u011f\u0131l\u0131m\u0131 %53 G\u00fc\u00e7l\u00fc Al ve %33 Al \u015feklindedir.<\/p>\n<p><strong>Sonu\u00e7: UZUN VADEL\u0130 YATIRIMCILAR \u0130\u00c7\u0130N G\u00dc\u00c7L\u00dc AL<\/strong>. Mevcut k\u00e2rl\u0131l\u0131k, b\u00fcy\u00fcme e\u011filimi ve pipeline potansiyelinin birle\u015fimi HRMY&#8217;yi son derece cazip k\u0131l\u0131yor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Tek \u00fcr\u00fcn ba\u011f\u0131ml\u0131l\u0131\u011f\u0131<\/strong>: WAKIX, 2030&#8217;a kadar gelirlerin \u00e7o\u011funu olu\u015fturuyor<\/li>\n<li><strong>Patent s\u00fcresi dolmas\u0131<\/strong>: Ocak 2030 sonras\u0131 jenerik rekabet m\u00fcmk\u00fcn<\/li>\n<li><strong>Reg\u00fclasyon zorluklar\u0131<\/strong>: De\u011fi\u015fen sa\u011fl\u0131k politikalar\u0131 fiyatlamay\u0131 etkileyebilir<\/li>\n<li><strong>Pipeline uygulamas\u0131<\/strong>: Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131 yat\u0131r\u0131mc\u0131 g\u00fcvenini sarsabilir<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>WAKIX hakimiyeti<\/strong>: 2025 2. \u00e7eyrekte %16 Y\u0131ll\u0131k b\u00fcy\u00fcme, 400 yeni hasta<\/li>\n<li><strong>Pipeline \u00e7e\u015fitlendirmesi<\/strong>: 13 programda 8 varl\u0131k geli\u015ftirme a\u015famas\u0131nda<\/li>\n<li><strong>Mali g\u00fc\u00e7<\/strong>: 610 milyon $ nakit rezerv + d\u00f6rt y\u0131l k\u00e2rl\u0131l\u0131k<\/li>\n<li><strong>Pazar geni\u015flemesi<\/strong>: Y\u0131ll\u0131k 3 milyar $+ gelir potansiyeli hedefleniyor<\/li>\n<li><strong>Son ortakl\u0131k<\/strong>: N\u00f6rolojik tedaviler i\u00e7in Circ Biosciences ile i\u015f birli\u011fi<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-5&#8217;ini temsil eden pozisyonla ba\u015flay\u0131n<\/li>\n<li><strong>Ortalama maliyetle al\u0131m<\/strong>: Kazan\u00e7 tarihleri civar\u0131nda kademeli al\u0131m yap\u0131n<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong>: Daha iyi giri\u015f i\u00e7in 36 $ alt\u0131 d\u00fc\u015f\u00fc\u015fleri takip edin<\/li>\n<li><strong>Uzun vadeye odaklan\u0131n<\/strong>: Bu, g\u00fcn de\u011fil y\u0131llarla \u00f6l\u00e7\u00fclen bir b\u00fcy\u00fcme hikayesi<\/li>\n<\/ol>\n<p>Espiri: &#8220;HRMY ticareti, uykululu\u011fu tedavi etmek gibidir\u2014uyanma \u00e7a\u011fr\u0131s\u0131 i\u00e7in sabra ihtiyac\u0131n\u0131z var. Acele etmek f\u0131rsatlar\u0131 ka\u00e7\u0131r\u0131r!&#8221;<\/p>\n<h2>\u2705 Harmony Biosciences Holdings, Inc. (HRMY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve d\u00fc\u015f\u00fck komisyon \u00fccretleri sa\u011flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Risk alabilece\u011finiz y\u00f6netilebilir bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;HRMY&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>Do\u011fru g\u00fcvenlik i\u00e7in tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>\u0130\u015flem \u00f6ncesi emir detaylar\u0131n\u0131 \u00e7ift kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyonu izleyin<\/td>\n<td>Kazan\u00e7 ve haber olaylar\u0131 i\u00e7in uyar\u0131lar kurun<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Yeniden yat\u0131r\u0131m d\u00fc\u015f\u00fcn\u00fcn<\/td>\n<td>Zay\u0131fl\u0131kta pozisyona ekleme planlay\u0131n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden \u00dcst\u00fcn?<\/h2>\n<p>Pocket Option, HRMY gibi hisselerle yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in ola\u011fan\u00fcst\u00fc avantajlar sunar:<\/p>\n<p><strong>Sadece 5 $ minimum depozito<\/strong>, ger\u00e7ek piyasa ko\u015fullar\u0131na eri\u015firken stratejileri d\u00fc\u015f\u00fck riskle test etmenizi sa\u011flar. Platformun <strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong> sayesinde tek bir kimlik belgesi y\u00fckleyip hemen i\u015flem yapmaya ba\u015flayabilirsiniz\u2014kazan\u00e7 a\u00e7\u0131klamalar\u0131 \u00e7evresinde f\u0131rsatlar\u0131 yakalamak i\u00e7in ideal.<\/p>\n<p><strong>100&#8217;den fazla para \u00e7ekme y\u00f6ntemi<\/strong> (kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil) ile yat\u0131r\u0131m getirilerinizi y\u00f6netmede esneklik sa\u011flars\u0131n\u0131z. D\u00fc\u015f\u00fck giri\u015f engelleri ve g\u00fc\u00e7l\u00fc ticaret ara\u00e7lar\u0131n\u0131n birle\u015fimi, Pocket Option&#8217;u HRMY pozisyonunuzu ad\u0131m ad\u0131m olu\u015fturmak i\u00e7in ideal k\u0131lar.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Harmony Biosciences: N\u00f6rolojinin Y\u00fckselen Y\u0131ld\u0131z\u0131<\/h2>\n<p>Harmony Biosciences, tek \u00fcr\u00fcnl\u00fc bir \u015firketten <strong>&#8220;yenilik\u00e7i, kataliz\u00f6r zengini, kendi kendini finanse eden bir biyoteknoloji \u015firketi&#8221;<\/strong> haline geldi ve y\u0131ll\u0131k 3 milyar $ \u00fczeri gelir potansiyeli hedefliyor (<a href=\"https:\/\/www.prnewswire.com\/news-releases\/harmony-biosciences-highlights-new-data-robust-late-stage-pipeline-with-near-term-value-creation-opportunities-and-its-bold-new-vision-at-investor-day-302263357.html\">\u015eirket Vizyonu<\/a>). Uykululuk hastal\u0131\u011f\u0131 i\u00e7in amiral gemisi WAKIX tedavisinin \u00f6tesinde, \u015firket art\u0131k 13 geli\u015ftirme program\u0131nda 8 varl\u0131\u011fa sahip.<\/p>\n<p>\u015eirketin finansal g\u00f6stergeleri biyoteknoloji sekt\u00f6r\u00fc i\u00e7in ola\u011fan\u00fcst\u00fcd\u00fcr: <strong>%78,34 br\u00fct marj<\/strong> ve <strong>%23,42 net k\u00e2r marj\u0131<\/strong> hem bilimsel yenilik hem de ticari m\u00fckemmeliyet g\u00f6steriyor (<a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-hrmy\/harmony-biosciences-holdings\">Finansal Analiz<\/a>). 610 milyon $ nakit rezerv ve s\u00fcrekli k\u00e2rl\u0131l\u0131kla Harmony, \u00e7o\u011fu \u015firketin ba\u015far\u0131ya ula\u015fmadan y\u0131llarca nakit yakt\u0131\u011f\u0131 bir sekt\u00f6rde \u00f6ne \u00e7\u0131k\u0131yor.<\/p>\n<p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025&#8217;te Harmony, SLEEP konferans\u0131nda BP1.15205 i\u00e7in \u00e7\u0131\u011f\u0131r a\u00e7an preklinik veriler sundu; bu deneysel bile\u015fik, uykululuk hastal\u0131\u011f\u0131 i\u00e7in s\u0131n\u0131f\u0131n\u0131n en iyisi tedavi olabilir\u2014uyku bozukluklar\u0131 tedavisinde bir kez daha devrim yaratma potansiyeline sahip!<\/p>\n"},"faq":[{"question":"Harmony Biosciences (HRMY) hisseleri nereden al\u0131nabilir?","answer":"HRMY hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"HRMY hisseleri i\u00e7in en iyi al\u0131m zaman\u0131 ne zaman?","answer":"Kazan\u00e7 raporlar\u0131 \u00f6ncesi ve sonras\u0131 d\u00f6nemler genellikle fiyat hareketlerinin y\u00fcksek oldu\u011fu zamanlard\u0131r. \u00d6zellikle 4 Kas\u0131m 2025'teki 3. \u00e7eyrek raporu \u00f6nemli olabilir."},{"question":"HRMY hisselerinin riskleri nelerdir?","answer":"Tek \u00fcr\u00fcn ba\u011f\u0131ml\u0131l\u0131\u011f\u0131, patent s\u00fcresi dolmas\u0131, reg\u00fclasyon zorluklar\u0131 ve klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131 ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar HRMY hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn k\u00fc\u00e7\u00fck bir y\u00fczdesiyle ba\u015flay\u0131n, dolar maliyeti ortalamas\u0131 yaparak kademeli al\u0131m ger\u00e7ekle\u015ftirin ve uzun vadeli d\u00fc\u015f\u00fcn\u00fcn."},{"question":"Pocket Option HRMY hisseleri i\u00e7in neden \u00f6neriliyor?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC s\u00fcreci ve \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ile yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygun ve esnek bir platformdur."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Harmony Biosciences (HRMY) hisseleri nereden al\u0131nabilir?","answer":"HRMY hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"HRMY hisseleri i\u00e7in en iyi al\u0131m zaman\u0131 ne zaman?","answer":"Kazan\u00e7 raporlar\u0131 \u00f6ncesi ve sonras\u0131 d\u00f6nemler genellikle fiyat hareketlerinin y\u00fcksek oldu\u011fu zamanlard\u0131r. \u00d6zellikle 4 Kas\u0131m 2025'teki 3. \u00e7eyrek raporu \u00f6nemli olabilir."},{"question":"HRMY hisselerinin riskleri nelerdir?","answer":"Tek \u00fcr\u00fcn ba\u011f\u0131ml\u0131l\u0131\u011f\u0131, patent s\u00fcresi dolmas\u0131, reg\u00fclasyon zorluklar\u0131 ve klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131 ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar HRMY hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn k\u00fc\u00e7\u00fck bir y\u00fczdesiyle ba\u015flay\u0131n, dolar maliyeti ortalamas\u0131 yaparak kademeli al\u0131m ger\u00e7ekle\u015ftirin ve uzun vadeli d\u00fc\u015f\u00fcn\u00fcn."},{"question":"Pocket Option HRMY hisseleri i\u00e7in neden \u00f6neriliyor?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC s\u00fcreci ve \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ile yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygun ve esnek bir platformdur."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Harmony Biosciences Holdings, Inc. (HRMY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Harmony Biosciences Holdings, Inc. (HRMY) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Harmony Biosciences Holdings, Inc. (HRMY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Harmony Biosciences Holdings, Inc. (HRMY) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T02:52:52+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Harmony Biosciences Holdings, Inc. (HRMY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Harmony Biosciences Holdings, Inc. (HRMY) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-29T02:52:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/\",\"name\":\"Harmony Biosciences Holdings, Inc. (HRMY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Harmony Biosciences Holdings, Inc. (HRMY) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"datePublished\":\"2025-08-29T02:52:52+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Harmony Biosciences Holdings, Inc. (HRMY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Harmony Biosciences Holdings, Inc. (HRMY) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Harmony Biosciences Holdings, Inc. (HRMY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Harmony Biosciences Holdings, Inc. (HRMY) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/","og_locale":"tr_TR","og_type":"article","og_title":"Harmony Biosciences Holdings, Inc. (HRMY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Harmony Biosciences Holdings, Inc. (HRMY) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-29T02:52:52+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Harmony Biosciences Holdings, Inc. (HRMY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Harmony Biosciences Holdings, Inc. (HRMY) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-29T02:52:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/","name":"Harmony Biosciences Holdings, Inc. (HRMY) Hisseleri Nas\u0131l Al\u0131n\u0131r - Harmony Biosciences Holdings, Inc. (HRMY) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","datePublished":"2025-08-29T02:52:52+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Harmony Biosciences Holdings, Inc. (HRMY) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Harmony Biosciences Holdings, Inc. (HRMY) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":355813,"slug":"how-to-buy-harmony-biosciences-holdings","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Harmony Biosciences Holdings, Inc. (HRMY) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Harmony Biosciences Holdings, Inc. (HRMY)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/"},"pt_AA":{"locale":"pt_AA","id":355812,"slug":"how-to-buy-harmony-biosciences-holdings","post_title":"Como comprar a\u00e7\u00f5es da Harmony Biosciences Holdings, Inc. (HRMY) - Investimento em a\u00e7\u00f5es da Harmony Biosciences Holdings, Inc. (HRMY)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-harmony-biosciences-holdings\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/355814","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=355814"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/355814\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334009"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=355814"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=355814"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=355814"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}